Lampera, Baby Girl .
HRN: 22-56-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2023
CEFOTAXIME 500MG (VIAL)
02/15/2023
02/21/2023
IV
70mg
Q12
1. RDS 2. Prematurity
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes